Alejandro H. Corvalán

5.1k total citations · 1 hit paper
126 papers, 3.2k citations indexed

About

Alejandro H. Corvalán is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Alejandro H. Corvalán has authored 126 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 40 papers in Oncology and 33 papers in Surgery. Recurrent topics in Alejandro H. Corvalán's work include Epigenetics and DNA Methylation (22 papers), Viral-associated cancers and disorders (20 papers) and RNA modifications and cancer (15 papers). Alejandro H. Corvalán is often cited by papers focused on Epigenetics and DNA Methylation (22 papers), Viral-associated cancers and disorders (20 papers) and RNA modifications and cancer (15 papers). Alejandro H. Corvalán collaborates with scholars based in Chile, United States and Japan. Alejandro H. Corvalán's co-authors include Gonzalo Carrasco-Aviño, Francisco Aguayo, Ignacio I. Wistuba, Iva Polakovičová, Yukari Eizuru, Milind Suraokar, Carmen Behrens, John D. Minna, Chihaya Koriyama and Suminori Akiba and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Alejandro H. Corvalán

120 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extracellular vesicles through the blood–brain barrier: a review

2022 177 citations Iva Polakovičová, Alejandro H. Corvalán et al. profile →

Peers

Countries citing papers authored by Alejandro H. Corvalán

Since Specialization

Citations

This map shows the geographic impact of Alejandro H. Corvalán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro H. Corvalán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro H. Corvalán more than expected).

Fields of papers citing papers by Alejandro H. Corvalán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro H. Corvalán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro H. Corvalán. The network helps show where Alejandro H. Corvalán may publish in the future.

Co-authorship network of co-authors of Alejandro H. Corvalán

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro H. Corvalán. A scholar is included among the top collaborators of Alejandro H. Corvalán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro H. Corvalán. Alejandro H. Corvalán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epstein-Barr Virus BARF1 Is Expressed in Lung Cancer and Is Associated with Cancer Progression 2024 ·Cells ·Julio Osorio, (unknown), Francisco J. Carvajal, Alejandro H. Corvalán, Andrés Castillo, Ezequiel M. Fuentes‐Pananá, (unknown), Carmen Romero, (unknown)	2
2	SLC7A11 Expression Is Up-Regulated in HPV- and Tobacco-Associated Lung Cancer 2024 ·International Journal of Molecular Sciences ·Julio Osorio, (unknown), Tarik Gheit, Alejandro H. Corvalán, (unknown)	1
3	Volatilomic signatures of different strains of Helicobacter pylori 2024 ·Helicobacter ·(unknown), (unknown), (unknown), (unknown), Clemens Ager, Alejandro H. Corvalán, Elmer A. Fernández, Chris A. Mayhew, Mārcis Leja, Paweł Mochalski	3
4	A snapshot of cancer in Chile II: an update on research, strategies and analytical frameworks for equity, innovation and national development 2024 ·Biological Research ·(unknown), (unknown), (unknown), Óscar Arteaga, Katherine Marcelain, Enrique A. Castellón, (unknown), (unknown), Bettina Müller, (unknown), Sofía P. Salas, Arnoldo Riquelme, Alejandro H. Corvalán, Jorge Jiménez de la Jara, Catterina Ferreccio, (unknown), (unknown), Juan Carlos Roa, Gareth I. Owen	0
5	Protein kinase B (AKT) upregulation and Thy-1-αvβ3 integrin-induced phosphorylation of Connexin43 by activated AKT in astrogliosis 2023 ·Journal of Neuroinflammation ·(unknown), Alejandro Chamorro-García, (unknown), (unknown), (unknown), Alejandro H. Corvalán, Brigitte van Zundert, (unknown), Pablo R. Moya, Ana M. Avalos, Pascal Schneider, Andrew F. G. Quest, Lisette Leyton	16
6	Volatilomic Signatures of AGS and SNU-1 Gastric Cancer Cell Lines 2022 ·Molecules ·(unknown), Christine Heinzle, Andreas Leiherer, Clemens Ager, Axel Muendlein, (unknown), Mārcis Leja, Alejandro H. Corvalán, Heinz Drexel, Agnieszka Królicka, (unknown), Chris A. Mayhew, Hossam Haick, Paweł Mochalski	10
7	Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives 2022 ·Pathogens ·Julio Osorio, Rancés Blanco, Alejandro H. Corvalán, Juan P. Muñoz, Gloria M. Calaf, Francisco Aguayo	9
8	Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway 2020 ·Cell Death and Differentiation ·Cristian Sotomayor-Flores, Pablo Rivera-Mejías, C. Vásquez, Camila López‐Crisosto, Pablo E. Morales, Christian Pennanen, Iva Polakovičová, Víctor Aliaga-Tobar, Lorena Garcı́a, Juan Carlos Roa, Beverly A. Rothermel, Vinicius Maracaja‐Coutinho, (unknown), Gunter Meister, Mario Chiong, María Paz Ocaranza, Alejandro H. Corvalán, Valentina Parra, Sergio Lavandero	40
9	The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Gonzalo Carrasco-Aviño, (unknown), (unknown), Julio Amigo, Enrique Norero, Franz Villarroel‐Espíndola, Arnoldo Riquelme, Marcelo Garrido, Gareth I. Owen, Alejandro H. Corvalán	14
10	Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis 2018 ·Gastroenterology ·Zheng Chen, Zheng Li, Mohammed Soutto, Weizhi Wang, M. Blanca Piazuelo, Shoumin Zhu, Yan Guo, (unknown), Alejandro H. Corvalán, Xi Chen, Zekuan Xu, Wael El‐Rifai	36
11	A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy 2015 ·Biological Research ·Jorge Jiménez de la Jara, Gabriel Bastías, Catterina Ferreccio, (unknown), (unknown), Camilo Cid, (unknown), Cristián Herrera, Bruno Nervi, Alejandro H. Corvalán, (unknown), (unknown), Enrique A. Castellón, Eva Bustamante, Sergio A. Oñate, (unknown), Richard Sullivan, Gareth I. Owen	25
12	A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients 2013 ·Clinical Cancer Research ·Hao Tang, Guanghua Xiao, Carmen Behrens, Joan H. Schiller, Jeffrey A. Allen, Chi‐Wan Chow, Milind Suraokar, Alejandro H. Corvalán, Jian‐Hua Mao, Michael A. White, Ignacio I. Wistuba, John D. Minna, Yang Xie	213
13	Bases epigenéticas del cáncer gástrico: oportunidades para la búsqueda de nuevos biomarcadores 2013 ·Revista médica de Chile ·Alejandro H. Corvalán	3
14	Overexpression of p73 as a Tissue Marker for High-Risk Gastritis 2010 ·Clinical Cancer Research ·Gonzalo Carrasco-Aviño, José I. Diaz, José R. Valbuena, (unknown), (unknown), (unknown), Carolina Rodríguez, Javiera Torres, Ignacio Duarte, (unknown), (unknown), (unknown), Alejandro H. Corvalán	17
15	Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features 2010 ·Clinical Cancer Research ·Luisa M. Solis, Carmen Behrens, Wenli Dong, Milind Suraokar, Natalie Ozburn, César A. Moran, Alejandro H. Corvalán, Shyam Biswal, Stephen G. Swisher, B. Nebiyou Bekele, John D. Minna, David J. Stewart, Ignacio I. Wistuba	357
16	Las prácticas cotidianas frente a los dispositivos de la movilidad: Aproximación política a la movilidad cotidiana de las poblaciones pobres periurbanas de Santiago de Chile 2010 ·EURE (Santiago) ·(unknown), Alejandro H. Corvalán	15
17	Reprimo as a Potential Biomarker for Early Detection in Gastric Cancer 2008 ·Clinical Cancer Research ·Carolina Bernal-Morales, Francisco Aguayo, (unknown), Macarena Vargas, Ignacio Díaz, Francisco J. Ossandon, (unknown), Mariana Palma, (unknown), (unknown), Alejandro H. Corvalán	99
18	Serial Analysis of Gene Expression Identifies Connective Tissue Growth Factor Expression as a Prognostic Biomarker in Gallbladder Cancer 2008 ·Clinical Cancer Research ·Héctor M. Álvarez, Alejandro H. Corvalán, Juan Carlos Roa, Pedram Argani, F. Murillo, Jennifer B. Edwards, Robert M. Beaty, Georg Feldmann, Seung‐Mo Hong, Michael E. Mullendore, Iván Roa, Luis Ibáñez, Fernando Pimentel, (unknown), Gregory J. Riggins, Anirban Maitra	33
19	Perfiles de expresión génica en decisiones terapéuticas en cáncer de mama 2007 ·Revista médica de Chile ·Alejandro H. Corvalán	0
20	Conocimientos, actitudes y prácticas acerca del VIH/SIDA en jóvenes de nivel medio de educación, del área metropolitana, Paraguay 2006 ·Scientific Electronic Library Online (Scientific Electronic Library Online) ·(unknown), (unknown), Alejandro H. Corvalán, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact